MNPR Monopar Therapeutics Inc. - Common Stock
$115,75
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$29–$125
91% of range
Analystenbewertung
BUY
19 analysts
Kursziel
$125
+8% upside
P/E (TTM)
—
ROE
—
Nettogewinnmarge
—
MNPR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$115.75
Marktkapitalisierung
—
P/E (TTM)
—
EPS (TTM)
—
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$29 – $125
MNPR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2016-12-31
→
2025-12-31
EPS
—
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MNPR
Peer-Median
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MNPR
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MNPR
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MNPR
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MNPR
Peer-Median
MNPR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
19 Analysten
- Starker Kauf 4 21,1%
- Kauf 14 73,7%
- Halten 1 5,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
13 Analysten · 2026-08-16
Median
$128.00
Jetzt
$115.75
Tief
$100.00
Hoch
$145.00
Median-Ziel
$128.00
+10,6%
Mittelwert-Ziel
$124.77
+7,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.28%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.46 | $-0.85 | 0.39% |
| 31. Dezember 2025 | $-0.64 | $-0.50 | -0.14% |
| 30. September 2025 | $-0.48 | $-0.44 | -0.04% |
| 30. Juni 2025 | $-0.35 | $-0.48 | 0.13% |
| 31. März 2025 | $-0.38 | $-0.69 | 0.31% |
| 31. Dezember 2024 | $-2.75 | $-0.43 | -2.3% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MNPR | — | — | — | — | — | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | — |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | — |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | — |
| ACHV | — | -4.0 | — | — | — | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $10M | $13M | $6M | $8M | $6M | $4M | $2M | $2M | $935.3K | |
| SG&A Expense | $7M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Operating Expenses | $17M | $16M | $9M | $11M | $9M | $7M | $4M | $3M | $17M | |
| Operating Income | $-17M | $-16M | $-9M | $-11M | $-9M | $-7M | $-4M | $-3M | $-17M | |
| Interest Income | $3M | $404.0K | $429.0K | · | · | · | · | · | · | |
| Pretax Income | $-14M | $-16M | $-8M | · | · | · | · | $-3M | $-17M | |
| Income Tax | $800 | $800 | $800 | $800 | $0 | $18.4K | $0 | $-70.8K | $-3.6K | |
| Net Income | $-14M | $-16M | $-8M | $-11M | $-9M | $-6M | $-4M | $-3M | $-17M | |
| EPS (Basic) | $-1.85 | $-4.11 | $-3.04 | $-0.83 | · | · | · | · | · | |
| Shares (Basic) | 7,411,121 | 3,790,202 | 2,764,790 | 12,718,166 | 12,471,217 | · | · | · | · | |
| EBITDA | · | $-16M | $-9M | $-11M | $-9M | $-7M | $-4M | $-3M | · |
Bilanz 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $62M | $46M | $7M | $8M | $20M | $17M | $13M | $7M | $9M | |
| Other Current Assets | $63.7K | $78.9K | $66.4K | $46.0K | $217.7K | $62.7K | $15.7K | · | · | |
| Current Assets | $140M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $9M | |
| Other Non-current Assets | · | · | · | · | $0 | $68.9K | $122.4K | $65.7K | · | |
| Total Assets | $141M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $10M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Current Liabilities | $3M | $5M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Capital Leases | $154.9K | $0 | $0 | $8.4K | $0 | · | · | · | · | |
| Total Liabilities | $3M | $5M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Common Stock | $6.7K | $6.1K | $3.0K | $12.9K | $12.6K | $11.5K | $10.6K | $9.3K | $9.3K | |
| Paid-in Capital | · | · | · | $62M | $60M | $48M | $39M | $29M | $28M | |
| Retained Earnings | $-90M | $-76M | $-60M | $-52M | $-41M | $-32M | $-26M | $-22M | $-18M | |
| AOCI | $131.4K | $36.0K | $-14.1K | $8.9K | $-3.2K | $-7.9K | $-11.0K | $-2.4K | $0 | |
| Stockholders' Equity | $138M | $55M | $6M | $10M | $19M | $16M | $13M | $7M | $10M | |
| Liabilities + Equity | $141M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $10M | |
| Shares Outstanding | 6,692,140 | 6,102,560 | 2,980,900 | 12,946,573 | 12,598,125 | 11,453,465 | 10,587,632 | 9,291,421 | 9,291,421 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $1M | $2M | $2M | · | · | · | · | · | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-71.6K | $0 | |
| Operating Cash Flow | $-12M | $-6M | $-8M | $-7M | $-7M | $-5M | $-3M | $-3M | $-3M | |
| Investing Cash Flow | $-63M | $-14M | $5M | $-5M | $0 | · | · | · | · | |
| Stock Issued | $0 | $4M | $2M | $109.3K | · | $8M | $0 | $0 | $5M | |
| Stock Repurchased | $35M | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $4M | $2M | · | · | $8M | · | $0 | · | |
| Financing Cash Flow | $92M | $59M | $2M | $32.9K | $11M | $8M | $9M | $-206.3K | $10M | |
| Net Change in Cash | $16M | $39M | $-920.1K | $-12M | $4M | $4M | $6M | $-3M | $7M | |
| Taxes Paid | · | · | · | · | $0 | $-11.1K | $53 | · | · |
Rentabilität 6
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -49611.0% | -37992.2% | -7947.2% | · | · | · | |
| Net Margin | · | · | · | -49511.0% | -37892.2% | -7697.7% | · | · | · | |
| EBITDA Margin | · | · | · | -49611.0% | -37992.2% | -7947.2% | · | · | · | |
| ROA | · | -46.1% | -81.7% | -62.3% | -48.7% | -41.7% | -40.9% | -37.4% | · | |
| ROE | · | -52.0% | -137.8% | -93.1% | -45.3% | -38.0% | -49.0% | -44.5% | · | |
| ROIC | · | -29.4% | · | · | · | · | · | -48.1% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.2 | 4.2 | · | 14.3 | 18.3 | 18.3 | · | |
| Quick Ratio | · | · | 4.1 | 2.6 | · | 14.2 | 18.2 | 17.3 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Bewertung (TTM) 6
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-14M | $-16M | $-8M | $-11M | $-9M | $-6M | $-4M | $-3M | $-17M | |
| Market Cap | · | $134M | $25M | $153M | $202M | $350M | $879M | · | · | |
| P/B | · | 2.4 | 4.5 | 15.2 | 10.7 | 22.3 | 69.6 | · | · | |
| P / Tangible Book | 3.2 | 2.4 | 4.5 | 15.2 | 10.7 | 22.3 | · | · | · | |
| P / Cash Flow | · | -21.0 | -3.2 | -21.2 | 27.6 | -75.2 | -291.2 | · | · |
Gewinn- und Verlustrechnung 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $5M | $3M | $4M | $3M | $2M | $2M | $10M | $984.3K | $1M | $966.1K | $1M | $1M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $590.6K | $657.8K | $757.3K | $876.4K | $749.5K | $733.5K | $871.7K | $806.0K | $675.1K | |
| Operating Expenses | $7M | $5M | $6M | $4M | $3M | $3M | $11M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Operating Income | $-7M | $-5M | $-6M | $-4M | $-3M | $-3M | $-11M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | |
| Interest Income | $1M | $1M | $954.4K | $655.5K | $780.8K | $596.8K | $149.0K | $99.3K | $73.5K | $82.2K | $98.1K | $112.3K | · | · | · | · | |
| Net Income | $-5M | $-4M | $-5M | $-3M | $-2M | $-3M | $-11M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | |
| EPS (Basic) | $-0.62 | $-0.46 | $-0.64 | $-0.48 | $-0.35 | $-0.38 | $-2.74 | $-0.37 | $-0.49 | $-0.51 | $-2.00 | $-0.69 | $-0.16 | $-0.19 | $-0.23 | $-0.19 | |
| Shares (Basic) | 8,542,450 | 8,535,443 | -13,698,191 | 7,123,849 | 6,998,082 | 6,987,381 | -6,429,086 | 3,520,398 | 3,502,927 | 3,195,963 | -26,584,750 | 2,823,680 | 13,420,029 | 13,105,831 | 53,779 | 12,754,685 | |
| EBITDA | $-7M | $-5M | · | $-4M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-3M | · | $-2M |
Bilanz 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $62M | $128M | $40M | $40M | $46M | $6M | $6M | $8M | $7M | $6M | $7M | $6M | $8M | $14M | |
| Other Current Assets | $464.7K | $250.9K | $63.7K | $414.8K | $497.3K | $523.6K | $78.9K | $49.6K | $61.0K | $119.0K | $66.4K | $73.2K | $109.9K | $106.8K | $46.0K | $55.7K | |
| Current Assets | $135M | $138M | $140M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Total Assets | $135M | $138M | $141M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Accounts Payable | $4M | $2M | $3M | $3M | $2M | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Current Liabilities | $4M | $2M | $3M | $3M | $2M | · | $5M | · | · | · | · | $2M | $3M | $3M | $3M | $2M | |
| Capital Leases | $107.8K | $131.6K | $154.9K | $70.9K | $80.4K | · | $0 | · | · | · | · | $0 | $0 | $0 | $8.4K | $20.9K | |
| Total Liabilities | $4M | $3M | $3M | $3M | $2M | $1M | $5M | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Common Stock | $6.7K | $6.7K | $6.7K | $6.7K | $6.1K | $6.1K | $6.1K | $3.5K | $17.6K | $17.5K | $3.0K | $14.2K | $13.9K | $13.2K | $12.9K | $12.9K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | · | $63M | · | $61M | |
| Retained Earnings | $-99M | $-93M | $-90M | $-84M | $-81M | $-78M | $-76M | $-65M | $-64M | $-62M | $-60M | $-58M | $-56M | $-54M | $-52M | $-49M | |
| AOCI | $91.3K | $98.5K | $131.4K | $11.7K | $77.6K | $-21.8K | $36.0K | $-11.0K | $8.3K | $4.2K | $-14.1K | $3.9K | $7.2K | $31.8K | $8.9K | $43.0K | |
| Stockholders' Equity | $131M | $135M | $138M | $142M | $52M | $54M | $55M | $5M | $6M | $7M | $6M | $7M | $8M | $9M | $10M | $13M | |
| Liabilities + Equity | $135M | $138M | $141M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Shares Outstanding | 6,712,172 | 6,699,062 | 6,692,140 | 6,662,930 | 6,127,457 | 6,115,214 | 6,102,560 | 3,525,079 | 17,601,827 | 17,484,175 | 2,980,900 | 14,198,438 | 13,898,081 | 13,222,056 | 12,946,573 | 12,855,735 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $1M | $1M | $1M | $1M | $278.6K | $199.1K | $334.4K | $328.7K | $474.2K | $474.1K | $473.3K | $476.2K | $393.4K | $390.7K | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-2M | $-1M | $-6M | $-2M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | |
| Investing Cash Flow | $4M | $-6M | $-62M | $-2M | $1M | $-325.8K | $-14M | $985.7K | $-2.4K | $-983.3K | $3M | $-13.1K | $3M | $-983.4K | $-5M | $0 | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $1M | $0 | $-1 | $3M | $339.9K | $254.9K | $657.8K | $821.6K | $109.3K | $0 | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $-647.4K | $-200.2K | $-384.7K | $92M | $-316.8K | $-115.7K | $56M | $-16.5K | $-9.9K | $3M | $334.5K | $246.7K | $641.2K | $804.8K | $138.7K | $-23.7K | |
| Net Change in Cash | $213.5K | $-9M | $-66M | $88M | $-209.5K | $-6M | $40M | $-99.8K | $-2M | $541.5K | $2M | $-2M | $1M | $-2M | $-6M | $-2M |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -2434.6% | -2097.5% | · | -1840.4% | -1815.8% | -2790.5% | · | -31272.3% | |
| Net Margin | · | · | · | · | · | · | · | · | -2334.6% | -1997.5% | · | -1740.4% | -1715.8% | -2690.5% | · | -31172.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -2434.6% | -2097.5% | · | -1840.4% | -1815.8% | -2790.5% | · | -31272.3% | |
| ROA | -5.6% | -4.0% | · | -4.6% | -8.0% | -8.2% | · | -17.8% | -19.6% | -15.8% | · | -17.0% | -16.2% | -16.3% | · | -13.0% | |
| ROE | -5.8% | -4.1% | · | -4.7% | -8.4% | -8.6% | · | -22.6% | -24.6% | -20.0% | · | -20.4% | -19.7% | -18.8% | · | -14.2% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 33.6 | 56.0 | · | 56.1 | 33.9 | · | · | · | · | · | · | 4.3 | 4.1 | 4.1 | · | 7.5 | |
| Quick Ratio | 13.1 | 21.4 | · | 49.7 | 24.9 | · | · | · | · | · | · | 2.8 | 2.9 | 2.0 | · | 7.5 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Bewertung (TTM) 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-15M | $-12M | · | $-10M | $-8M | $-7M | · | $-7M | $-8M | $-8M | · | $-9M | $-10M | $-10M | · | $-10M | |
| Market Cap | $621M | $367M | · | $544M | $219M | $223M | · | $24M | $64M | $60M | · | $44M | $59M | $92M | · | $98M | |
| P/B | 4.7 | 2.7 | · | 3.8 | 4.2 | 4.2 | · | 4.8 | 10.5 | 8.0 | · | 6.7 | 7.6 | 10.3 | · | 7.8 | |
| P / Tangible Book | 4.7 | 2.7 | · | 3.8 | 4.2 | 4.2 | · | 4.8 | 10.5 | 8.0 | · | 6.7 | 7.6 | 10.3 | · | 7.8 | |
| P / Cash Flow | · | -105.7 | · | · | · | -39.3 | · | · | · | -36.0 | · | · | · | -40.5 | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $0 | $0 | $0 | — | — |
| Betriebsgewinnmarge % | — | — | — | -49611.0% | -37992.2% |
| Nettoergebnis | $-14M | $-16M | $-8M | $-11M | $-9M |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | — | — | 4.2 | 4.2 | — |
| Quick Ratio | — | — | 4.1 | 2.6 | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 100 Einreicher · $468.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 35 (+20 vs. Vorquartal) | 14 (+5 vs. Vorquartal) | 26 (-1 vs. Vorquartal) | 24 (+2 vs. Vorquartal) | -997K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $72.062.327 | 1.317.410 | 15,37% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $61.776.696 | 667.207 | 13,18% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $29.975.550 | 323.745 | 6,39% | Aktien |
| Saturn V Capital Management LP | $28.885.858 | 311.976 | 6,16% | Aktien |
| Siren, L.L.C. | $25.010.226 | 270.118 | 5,33% | Aktien |
| ADAR1 Capital Management, LLC | $20.147.121 | 217.595 | 4,30% | Aktien |
| Polar Capital Holdings Plc | $19.857.685 | 214.469 | 4,24% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.417.141 | 209.711 | 4,14% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $19.369.365 | 209.195 | 4,13% | Aktien |
| TCG Crossover Management, LLC | $18.826.047 | 203.327 | 4,02% | Aktien |
| ORBIMED ADVISORS LLC | $14.575.796 | 157.423 | 3,11% | Aktien |
| Candriam S.C.A. | $13.258.989 | 143.339 | 2,83% | Aktien |
| Balyasny Asset Management L.P. | $12.457.336 | 134.543 | 2,66% | Aktien |
| Alyeska Investment Group, L.P. | $9.259.000 | 100.000 | 1,97% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $8.975.407 | 96.907 | 1,91% | Aktien |
| STATE STREET CORP | $8.569.297 | 92.551 | 1,83% | Aktien |
| Vivo Capital, LLC | $8.379.395 | 90.500 | 1,79% | Aktien |
| Driehaus Capital Management LLC | $7.781.264 | 84.040 | 1,66% | Aktien |
| Vestal Point Capital, LP | $7.011.563 | 75.727 | 1,50% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $6.686.294 | 72.214 | 1,43% | Aktien |
| Longaeva Partners L.P. | $5.169.670 | 55.834 | 1,10% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $4.658.295 | 50.311 | 0,99% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.519.873 | 48.816 | 0,96% | Aktien |
| Ikarian Capital, LLC | $4.431.450 | 47.861 | 0,95% | Aktien |
| CITADEL ADVISORS LLC | $3.426.200 | 37.004 | 0,73% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $3.394.535 | 36.662 | 0,72% | Aktien |
| Bank of New York Mellon Corp | $3.174.356 | 34.284 | 0,68% | Aktien |
| STEMPOINT CAPITAL LP | $2.789.274 | 30.125 | 0,59% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.618.445 | 28.280 | 0,56% | Aktien |
| UBS Group AG | $2.513.078 | 27.142 | 0,54% | Aktien |
| VANGUARD GROUP INC | $1.873.914 | 28.697 | 0,40% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.648.102 | 17.800 | 0,35% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.360.055 | 14.689 | 0,29% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.291.908 | 13.953 | 0,28% | Aktien |
| Ishara Investments LP | $1.138.857 | 12.300 | 0,24% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.134.413 | 12.252 | 0,24% | Aktien |
| Trexquant Investment LP | $1.111.450 | 12.004 | 0,24% | Aktien |
| GOLDMAN SACHS GROUP INC | $738.498 | 7.976 | 0,16% | Aktien |
| XTX Topco Ltd | $605.168 | 6.536 | 0,13% | Aktien |
| Nuveen, LLC | $553.688 | 5.980 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $521.271 | 5.630 | 0,11% | Aktien |
| GERBER, LLC | $518.597 | 5.601 | 0,11% | Aktien |
| Virtus Investment Advisers, LLC | $506.838 | 5.474 | 0,11% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $506.838 | 5.474 | 0,11% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $490.727 | 5.300 | 0,10% | Aktien |
| Aquatic Capital Management LLC | $354.342 | 3.827 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $352.953 | 3.812 | 0,08% | Aktien |
| Engineers Gate Manager LP | $322.121 | 3.479 | 0,07% | Aktien |
| BANK OF AMERICA CORP /DE/ | $300.918 | 3.250 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $269.252 | 2.908 | 0,06% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $260.800 | 4.760 | 0,06% | Aktien |
| EP Wealth Advisors, LLC | $241.012 | 2.603 | 0,05% | Aktien |
| Entropy Technologies, LP | $240.734 | 2.600 | 0,05% | Aktien |
| WINTON GROUP Ltd | $231.475 | 2.500 | 0,05% | Aktien |
| GABELLI FUNDS LLC | $231.475 | 2.500 | 0,05% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $228.605 | 2.469 | 0,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $222.216 | 2.400 | 0,05% | Aktien |
| Martin Investment Management, LLC | $215.457 | 2.327 | 0,05% | Aktien |
| Schonfeld Strategic Advisors LLC | $213.882 | 2.310 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $192.217 | 2.076 | 0,04% | Aktien |
| CITIGROUP INC | $169.255 | 1.828 | 0,04% | Aktien |
| Invesco Ltd. | $165.088 | 1.783 | 0,04% | Aktien |
| DIADEMA PARTNERS LP | $150.922 | 1.630 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $143.792 | 1.553 | 0,03% | Aktien |
| Quarry LP | $139.070 | 1.502 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $135.922 | 1.468 | 0,03% | Aktien |
| AlphaQuest LLC | $129.490 | 1.983 | 0,03% | Aktien |
| MEEDER ASSET MANAGEMENT INC | $128.608 | 1.389 | 0,03% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $124.996 | 1.350 | 0,03% | Aktien |
| BlackRock, Inc. | $115.460 | 1.247 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $68.609 | 741 | 0,01% | Aktien |
| BARCLAYS PLC | $66.387 | 717 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $65.554 | 708 | 0,01% | Aktien |
| NewEdge Advisors, LLC | $55.554 | 600 | 0,01% | Aktien |
| FMR LLC | $49.073 | 530 | 0,01% | Aktien |
| Legal & General Group Plc | $43.054 | 465 | 0,01% | Aktien |
| Persistent Asset Partners Ltd | $38.147 | 412 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $37.869 | 409 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $31.944 | 345 | 0,01% | Aktien |
| Creative Planning | $31.295 | 338 | 0,01% | Aktien |
| JPMORGAN CHASE & CO | $18.628 | 197 | 0,00% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $13.533 | 247 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $13.000 | 136 | 0,00% | Aktien |
| Allworth Financial LP | $10.278 | 111 | 0,00% | Aktien |
| Russell Investments Group, Ltd. | $9.815 | 106 | 0,00% | Aktien |
| C M BIDWELL & ASSOCIATES LTD | $8.703 | 94 | 0,00% | Aktien |
| DEUTSCHE BANK AG\ | $8.333 | 90 | 0,00% | Aktien |
| Sterling Capital Management LLC | $6.666 | 72 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $3.333 | 36 | 0,00% | Aktien |
| Global Retirement Partners, LLC | $2.963 | 32 | 0,00% | Aktien |
| GAMMA Investing LLC | $2.315 | 25 | 0,00% | Aktien |
| Farther Finance Advisors, LLC | $2.222 | 24 | 0,00% | Aktien |
| CWM, LLC | $822 | 15 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $697 | 7.532 | 0,00% | Aktien |
| MORGAN STANLEY | $556 | 6 | 0,00% | Aktien |
| US BANCORP \DE\ | $556 | 6 | 0,00% | Aktien |
| PNC Financial Services Group, Inc. | $556 | 6 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $343 | 3.699 | 0,00% | Aktien |
| Arax Advisory Partners | $278 | 3 | 0,00% | Aktien |
| Integrated Wealth Concepts LLC | $93 | 1 | 0,00% | Aktien |
Unternehmensinsider 4 Insider · 3 Führungskräfte · 2 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robinson Chandler | Chief Executive Officer | 30. Juni 2026 M | 99.267 | 0 | 0 | $0 |
| Quan Anh Vu | Chief Financial Officer | 30. Juni 2026 M | 2.221 | 0 | 0 | $0 |
| Andrew Cittadine | Chief Operating Officer | 30. Juni 2026 M | 55.614 | 0 | 0 | $0 |
| Nicole Sweeny | Direktor | 26. Juni 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Tactic Pharma LLC, Robinson Chandler, Brown Michael J ×4 Einreichungen | 30. Januar 2026 | 4,50% | Änderung | — | SEC |
| Monopar Therapeutics, Hendricks Diane, Leo Karl, Pharma Investments LLC | 7. Februar 2025 | 13,40% | Änderung | — | SEC |
| GEM PHARMACEUTICALS LLC, DIANE HENDRICKS, KARL LEO, ARTHUR KLAUSNER, PHARMA INVESTMENTS LLC | 23. Dezember 2019 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 21 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,52% | 3.699 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,12% | 15.284 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,08% | 18.350 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,03% | 31.439 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 3.112 NS | 31. Mai 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 2.949 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 116.348 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 25.913 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.184 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 10.218 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 208 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 1.948 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 163 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1.318 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 162 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 9.937 SH | 8. August 2026 | Täglich |
| HDG · ProShares Trust | 0,00% | 4 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 1.833 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 45.173 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 159.786 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 420 SH | 8. August 2026 | Täglich |